These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37579382)

  • 21. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore.
    Kim S; Goh Y; Kang JHB
    Global Health; 2022 Sep; 18(1):82. PubMed ID: 36131348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic analysis of global health research funding in Canada, 2000-2016.
    Hoffman SJ; Gunn E; Rogers Van Katwyk S; Nixon S
    Can J Public Health; 2020 Feb; 111(1):80-95. PubMed ID: 31696423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoting equitable global health research: a policy analysis of the Canadian funding landscape.
    Plamondon K; Walters D; Campbell S; Hatfield J
    Health Res Policy Syst; 2017 Aug; 15(1):72. PubMed ID: 28851388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Inconsistent Canadian Provincial and Territorial Response During the Early COVID-19 Pandemic.
    Cyr A; Mondal P; Hansen G
    Front Public Health; 2021; 9():708903. PubMed ID: 34646800
    [No Abstract]   [Full Text] [Related]  

  • 27. Governments' accountability for Canada's pandemic response.
    Khoury L; Klein A; Couture-Ménard ME; Hammond K
    J Public Health Policy; 2022 Jun; 43(2):222-233. PubMed ID: 35414692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of non-invasive prenatal testing in Ontario and Quebec: the role of governing style in health technology innovation & adoption.
    Saleh L; Parker G; Stevenson M; Miller FA
    BMC Health Serv Res; 2023 Mar; 23(1):231. PubMed ID: 36890546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National expenditure on health research in South Africa: How has the landscape changed in the past decade?
    Barnabé MA; Gordon R; Ramjee G; Loots G; Blackburn JM
    S Afr Med J; 2020 Mar; 110(4):274-283. PubMed ID: 32657738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Contextual Factors in Private Sector Engagement: A Case Study of Private Sector Contribution to COVID-19 Mitigation in Nigeria.
    Okeke C; Eigbiremolen GO; Uzochukwu B; Mbachu C; Onwujekwe O
    Front Public Health; 2022; 10():915330. PubMed ID: 35801254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a COVID-19 Web Information Transmission Structure Based on a Quadruple Helix Model: Webometric Network Approach Using Bing.
    Zhu YP; Park HW
    J Med Internet Res; 2021 Aug; 23(8):e27681. PubMed ID: 34280119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for Canada's National Action Plan to End Gender-Based Violence: perspectives from leaders, service providers and survivors in Canada's largest city during the COVID-19 pandemic.
    Yakubovich AR; Steele B; Moses C; Tremblay E; Arcenal M; O'Campo P; Mason R; Du Mont J; Huijbregts M; Hough L; Sim A; Shastri P
    Health Promot Chronic Dis Prev Can; 2023 Apr; 43(4):155-170. PubMed ID: 36651882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19.
    Paradise J
    Am J Law Med; 2021 Jul; 47(2-3):157-175. PubMed ID: 34405779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Vaccination and Public Health Countermeasures on Variants of Concern in Canada: Evidence From a Spatial Hierarchical Cluster Analysis.
    Adeyinka DA; Neudorf C; Camillo CA; Marks WN; Muhajarine N
    JMIR Public Health Surveill; 2022 May; 8(5):e31968. PubMed ID: 35486447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Public Opinions and Concerns Regarding the Canadian Prime Minister's Daily COVID-19 Briefing: Longitudinal Study of YouTube Comments Using Machine Learning Techniques.
    Zheng C; Xue J; Sun Y; Zhu T
    J Med Internet Res; 2021 Feb; 23(2):e23957. PubMed ID: 33544690
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.